SIGA
SIGA Technologies: A US-based pharmaceutical firm specializing in oral antiviral drugs for smallpox treatment.
- 39
- Public company
- New York, NY, USUnited States
Founded in the United States, SIGA Technologies is a commercial-stage pharmaceutical company dedicated to developing and providing antiviral drugs, with a core mission to combat infectious diseases. The company's primary product is an oral formulation designed to treat human smallpox disease caused by the variola virus. SIGA focuses on expanding its market reach and product pipeline to address unmet medical needs in antiviral treatments.
Notable figures affiliated with SIGA Technologies include a team of experienced scientists and business leaders who drive the company's innovation and growth. The company has established a rich history of successful partnerships that bolster its mission. Key achievements include the development and commercialization of its antiviral drug, which has had a significant impact on public health preparedness against smallpox.
Similar Companies
Sigyn Therapeutics
Enanta Pharmaceuticals
enanta.com
Rigel Pharmaceuticals
rigel.com
Gilead Sciences
gilead.com
Sequella
sequella.com
Savoy Pharmaceuticals
Atea Pharmaceuticals
ateapharma.com
Emergent BioSolutions
Globavir Biosciences
KalVista Pharmaceuticals
kalvista.com
Soligenix
Salix Pharmaceuticals
salix.com
Assertio Holdings
Gemmus Pharma
gemmuspharma.com
Antios Therapeutics
SIG
Tega Therapeutics
Siwa Biotech
Tioga Pharmaceuticals
tiogapharma.com
Quick Facts
Who are SIGA's competitors?
Companies similar to SIGA include Sigyn Therapeutics, Enanta Pharmaceuticals, Rigel Pharmaceuticals and Gilead Sciences.
When was SIGA founded?
SIGA was founded in 1995.
Where is SIGA's headquarters located?
SIGA's headquarters is located in New York, NY, US.
When was SIGA's last funding round?
SIGA's most recent funding round was for $23M (USD) in June 2020.
How much disclosed funding has SIGA raised?
As of Jun 17, 2020, SIGA has disclosed funding of $110.6M (USD). Undisclosed round amounts are excluded.
How many employees does SIGA have?
SIGA has 39 employees as of Feb 6, 2024.
Classification
- Customer
- Main Product
- Tags
- Also Known As
- SIGA Technologies Inc.
- SIGA PHARMACEUTICALS INC
- Headquarters
- 31 East 62nd Street
- New York, NY, 10065
- US
- Ticker
- SIGA
- SEC CIK
- 0001010086
- EIN
- 13-3864870
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 2830Drugs
- 2834Pharmaceutical Preparations
- ISIC
- 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 14 more industry codes
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 620000Health Care and Social Assistance
- 541000Professional, Scientific, and Technical Services
- 623000Nursing and Residential Care Facilities
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 4000Railroad Transportation
- 8000Health Services
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8730Research, Development, And Testing Services
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- 8731Commercial Physical and Biological Research